Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract

Clinical trial NCT01116622 · COMPLETED

Trial details

NCT number: NCT01116622
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

Start date: 2003-04-01
Primary completion: 2014-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.